Cellectricon Announces Cellaxess-HT High Throughput Electroporation System
Complete the form below to unlock access to ALL audio articles.
Cellectricon announced collaboration with EPFL (Ecole Polytechnique Federale de Lausanne, Switzerland). EPFL is evaluating Cellectricon’s next-generation high throughput electroporation system. Cellaxess-HT is the world’s first high throughput electroporation system tailor-made for genome wide RNAi screening and will be launched Q2 2008.
"We are pleased to collaborate with EPFL and look forward to bringing this state-of-the-art system to the market.” says Dr. Mattias Karlsson, CEO at Cellectricon. “Cellaxess-HT will be the first of its kind on the market and will significantly impact drug discovery by opening the door to using more biologically relevant cell types in genome wide RNAi screening.”
“We are impressed by the unprecedented high throughput delivery of genetic materials the Cellaxess-HT system offers. We believe that Cellaxess-HT has the potential to greatly advance our efforts in our RNAi research programs”, says Dr. Gerardo Turcatti, Director of the Biomolecular Screening Facility at EP FL, Lausanne, Switzerland.
